Sandia researchers look for genetic bullet against COVID-19

Researchers at Sandia National Laboratories are using genetic resequencing tools to find ways to stop the virus behind the COVID-19 pandemic.

Biochemist Joe Schoeniger and virologist Oscar Negrete’s work involves genetically engineering a deployable antiviral countermeasure for COVID-19 using CRISPR-based technology.

“The goal is to find new ‘reloadable’ countermeasures for viral outbreaks that do not have to be re-invented every time,” Schoeniger explained. “CRISPR is a technology that allows us to address specific sequences of DNA and RNA, safely editing genes or controlling gene expression, to target viruses and improve the body’s ability to resist infection.”

Get the full story on our sister site R&D World.